| Ranked [title] Word list | Historiographs | Help Glossary HistCite Guide About |
| View: Overview | Sorted by GCS. |
| # | Word | Pubs | TLCS | TGCS |
|---|---|---|---|---|
| 201 | SEXISM | 3 | 30 | 136 |
| 202 | SURGERY | 26 | 6 | 135 |
| 203 | PASSIVE | 3 | 3 | 134 |
| 204 | STATE | 20 | 10 | 133 |
| 205 | SUPPORT | 17 | 15 | 133 |
| 206 | MORTALITY | 16 | 5 | 132 |
| 207 | COMPETENCE | 15 | 13 | 131 |
| 208 | INTERNAL-MEDICINE | 9 | 43 | 131 |
| 209 | SARCOMA | 5 | 6 | 131 |
| 210 | IMPLICIT | 7 | 30 | 130 |
| 211 | MEDIA | 8 | 1 | 130 |
| 212 | NEPOTISM | 3 | 26 | 130 |
| 213 | WELL | 9 | 39 | 130 |
| 214 | MEETING | 15 | 21 | 129 |
| 215 | ADMINISTRATIVE | 3 | 4 | 128 |
| 216 | ELECTRONIC | 37 | 13 | 128 |
| 217 | LESSONS | 14 | 4 | 128 |
| 218 | CONTINUING | 18 | 13 | 127 |
| 219 | PAPERS | 24 | 43 | 127 |
| 220 | SIGNIFICANCE | 3 | 5 | 127 |
| 221 | INITIALLY | 1 | 11 | 126 |
| 222 | TIME | 26 | 14 | 126 |
| 223 | GROUP | 32 | 16 | 125 |
| 224 | SOLUTIONS | 3 | 3 | 125 |
| 225 | LABORATORY | 17 | 1 | 124 |
| 226 | RANDOMISED | 7 | 47 | 124 |
| 227 | MEASUREMENT | 6 | 2 | 122 |
| 228 | ATYPICAL | 2 | 2 | 121 |
| 229 | FUNDING | 37 | 27 | 121 |
| 230 | HISTOPATHOLOGY | 3 | 6 | 121 |
| # | Word | Pubs | TLCS | TGCS |
| 231 | INNOVATION | 8 | 50 | 121 |
| 232 | ORGANIZATIONS | 27 | 19 | 121 |
| 233 | REACH | 1 | 3 | 119 |
| 234 | CELLS | 2 | 2 | 118 |
| 235 | SOFT-TISSUE | 2 | 6 | 118 |
| 236 | CRITIQUE | 7 | 4 | 116 |
| 237 | HOSPITALS | 20 | 8 | 116 |
| 238 | INVESTIGATION | 9 | 43 | 116 |
| 239 | PHILOSOPHICAL | 3 | 51 | 116 |
| 240 | RELATIONSHIP | 8 | 4 | 116 |
| 241 | ACADEMIC | 39 | 19 | 115 |
| 242 | HEART | 8 | 1 | 115 |
| 243 | PROFESSIONAL | 31 | 25 | 115 |
| 244 | ANNALS | 5 | 42 | 114 |
| 245 | CONTINUOUS | 14 | 5 | 114 |
| 246 | EVALUATIONS | 13 | 19 | 114 |
| 247 | INTERLABORATORY | 1 | 2 | 114 |
| 248 | MONITORS | 1 | 2 | 114 |
| 249 | SQUAMOUS | 1 | 2 | 114 |
| 250 | STANDARDIZED | 3 | 0 | 114 |
| 251 | UNDETERMINED | 1 | 2 | 114 |
| 252 | DISORDER | 3 | 0 | 112 |
| 253 | LOCAL | 10 | 12 | 112 |
| 254 | RECOMMENDATIONS | 17 | 32 | 112 |
| 255 | FAILURE | 5 | 3 | 111 |
| 256 | OUTCOME | 19 | 15 | 111 |
| 257 | PAYMENT | 4 | 2 | 111 |
| 258 | REGISTRY | 2 | 3 | 111 |
| 259 | DISORDERS | 10 | 1 | 110 |
| 260 | PHASE | 7 | 6 | 110 |
| # | Word | Pubs | TLCS | TGCS |
| 261 | STATISTICAL | 9 | 11 | 110 |
| 262 | COSTS | 6 | 2 | 109 |
| 263 | PREDICTING | 2 | 2 | 109 |
| 264 | UPDATE | 11 | 6 | 109 |
| 265 | MAPPING | 6 | 2 | 108 |
| 266 | PROBLEM | 9 | 19 | 108 |
| 267 | SCHEMES | 2 | 2 | 108 |
| 268 | ACCEPTANCE | 16 | 55 | 107 |
| 269 | PANIC | 1 | 0 | 107 |
| 270 | POLICIES | 12 | 31 | 107 |
| 271 | BASIS | 1 | 48 | 106 |
| 272 | SUPPRESSION | 1 | 48 | 106 |
| 273 | TRAINING | 25 | 21 | 106 |
| 274 | DETECT | 3 | 25 | 105 |
| 275 | DOCTOR-WATCHERS | 1 | 25 | 105 |
| 276 | HOSPITAL-CARE | 2 | 25 | 105 |
| 277 | RURAL | 4 | 0 | 105 |
| 278 | WATCHING | 1 | 25 | 105 |
| 279 | DECISION-MAKING | 6 | 8 | 104 |
| 280 | DEFENSE | 9 | 7 | 104 |
| 281 | INDUSTRY | 10 | 2 | 104 |
| 282 | AUTHOR | 13 | 58 | 103 |
| 283 | MASKING | 7 | 58 | 103 |
| 284 | PATTERNS | 10 | 7 | 103 |
| 285 | BREAST | 8 | 3 | 102 |
| 286 | SURVEY | 24 | 31 | 102 |
| 287 | EDITORS | 32 | 47 | 101 |
| 288 | ISSUES | 23 | 9 | 101 |
| 289 | BONE | 6 | 4 | 100 |
| 290 | CHART | 2 | 3 | 100 |
| # | Word | Pubs | TLCS | TGCS |
| 291 | CRITICAL | 21 | 9 | 100 |
| 292 | SYMPOSIUMS | 2 | 4 | 100 |
| 293 | CRITICAL-EVALUATION | 2 | 1 | 99 |
| 294 | SEPSIS | 2 | 1 | 99 |
| 295 | TECHNICAL | 7 | 2 | 99 |
| 296 | AGENDA | 4 | 39 | 97 |
| 297 | BIOEQUIVALENCE | 3 | 0 | 97 |
| 298 | EUROPEAN | 18 | 15 | 97 |
| 299 | SYSTEMATIC | 11 | 21 | 97 |
| 300 | EDUCATIONAL | 14 | 7 | 96 |
| 301 | RISK | 23 | 4 | 96 |
| 302 | TOXICOLOGY | 6 | 3 | 96 |
| 303 | TYPES | 3 | 1 | 96 |
| 304 | DISEASE | 20 | 1 | 95 |
| 305 | OTITIS | 1 | 0 | 95 |
| 306 | CHARACTERISTICS | 12 | 9 | 94 |
| 307 | CONTROL | 24 | 21 | 94 |
| 308 | CROSS-DISCIPLINARY | 1 | 41 | 94 |
| 309 | UNIVERSITY | 21 | 5 | 94 |
| 310 | PNEUMONIA | 3 | 0 | 93 |
| 311 | SETTINGS | 2 | 0 | 93 |
| 312 | ANGIOTENSIN-CONVERTING | 1 | 0 | 92 |
| 313 | ENZYME | 1 | 0 | 92 |
| 314 | COUNTRIES | 11 | 15 | 91 |
| 315 | ETHICS | 22 | 25 | 91 |
| 316 | MICE | 3 | 2 | 91 |
| 317 | REFERENCE | 6 | 12 | 91 |
| 318 | DIABETES-MELLITUS | 2 | 2 | 90 |
| 319 | RATE | 8 | 2 | 90 |
| 320 | PANEL | 17 | 3 | 89 |
| # | Word | Pubs | TLCS | TGCS |
| 321 | ANALYSES | 3 | 2 | 88 |
| 322 | ELDERLY | 6 | 3 | 88 |
| 323 | CLINIC | 5 | 3 | 87 |
| 324 | COST-UTILITY | 3 | 2 | 87 |
| 325 | DEFINITION | 4 | 0 | 87 |
| 326 | FEEDBACK | 13 | 14 | 87 |
| 327 | GASTROINTESTINAL | 1 | 0 | 87 |
| 328 | MOTILITY | 1 | 0 | 87 |
| 329 | FREQUENCY | 5 | 5 | 86 |
| 330 | REIMBURSEMENT | 1 | 2 | 86 |
| 331 | WEB-BASED | 16 | 5 | 86 |
| 332 | FETAL | 2 | 0 | 85 |
| 333 | PROGRAMS | 17 | 10 | 85 |
| 334 | TWO | 17 | 19 | 85 |
| 335 | VARIABILITY | 5 | 9 | 85 |
| 336 | COMPLICATIONS | 7 | 4 | 84 |
| 337 | CONGRESS | 18 | 41 | 84 |
| 338 | HIGH | 5 | 7 | 84 |
| 339 | IDENTITY | 4 | 49 | 84 |
| 340 | RADIOLOGY | 12 | 12 | 84 |
| 341 | SMALL | 12 | 11 | 84 |
| 342 | EVOLUTION | 14 | 29 | 83 |
| 343 | KNOWLEDGE | 14 | 3 | 83 |
| 344 | REVIEWER | 17 | 45 | 83 |
| 345 | STEADY | 1 | 0 | 83 |
| 346 | SYSTEMS | 24 | 11 | 83 |
| 347 | THERAPY | 15 | 6 | 83 |
| 348 | TRANSPLANTATION | 3 | 0 | 83 |
| 349 | CANADIAN | 11 | 0 | 82 |
| 350 | GENERAL-PRACTICE | 8 | 6 | 82 |
| # | Word | Pubs | TLCS | TGCS |
| 351 | HEALTH-CARE | 14 | 6 | 82 |
| 352 | LEARNED | 9 | 7 | 82 |
| 353 | ADVERSE | 7 | 7 | 81 |
| 354 | OPINIONS | 4 | 13 | 81 |
| 355 | PATIENT | 19 | 12 | 81 |
| 356 | ANNUAL | 9 | 2 | 80 |
| 357 | HOME | 7 | 0 | 80 |
| 358 | STRATEGIES | 10 | 0 | 80 |
| 359 | SWINE | 1 | 0 | 80 |
| 360 | LIVER | 3 | 1 | 79 |
| 361 | PART | 11 | 24 | 79 |
| 362 | BMJ | 3 | 31 | 78 |
| 363 | MULTICENTRE | 3 | 2 | 78 |
| 364 | DEPRESSIVE | 5 | 0 | 77 |
| 365 | MOVING | 3 | 1 | 77 |
| 366 | ACTIVITIES | 13 | 2 | 76 |
| 367 | EMBARGOES | 3 | 11 | 76 |
| 368 | FEMALE | 4 | 0 | 76 |
| 369 | GENDER | 4 | 22 | 76 |
| 370 | INGELFINGER | 3 | 11 | 76 |
| 371 | PRESSURE | 9 | 4 | 76 |
| 372 | ADULT | 6 | 0 | 75 |
| 373 | AMINOGLUTETHIMIDE | 1 | 0 | 75 |
| 374 | AUTHORS | 21 | 42 | 75 |
| 375 | CORE | 4 | 16 | 75 |
| 376 | EXEMESTANE | 1 | 0 | 75 |
| 377 | HORMONAL | 1 | 0 | 75 |
| 378 | MULTINATIONAL | 1 | 0 | 75 |
| 379 | POSTMENOPAUSAL | 1 | 0 | 75 |
| 380 | PROGRESSING | 1 | 0 | 75 |
| # | Word | Pubs | TLCS | TGCS |
| 381 | SPECIALTY | 4 | 10 | 75 |
| 382 | THIRD-LINE | 1 | 0 | 75 |
| 383 | AIR | 3 | 1 | 74 |
| 384 | ALLOCATION | 3 | 0 | 74 |
| 385 | CHANGE | 21 | 7 | 74 |
| 386 | ENGLAND | 7 | 4 | 74 |
| 387 | FACTOR | 12 | 11 | 74 |
| 388 | FACULTY | 16 | 3 | 74 |
| 389 | REFORM | 20 | 29 | 74 |
| 390 | SUCCESSFUL | 10 | 4 | 74 |
| 391 | ASSOCIATION | 14 | 5 | 73 |
| 392 | CARCINOGENICITY | 2 | 2 | 73 |
| 393 | COMPLICATION | 1 | 2 | 73 |
| 394 | PROVIDED | 4 | 1 | 73 |
| 395 | SCREEN | 1 | 2 | 73 |
| 396 | SET | 6 | 9 | 73 |
| 397 | APPLICATION | 20 | 12 | 72 |
| 398 | B6C3F | 1 | 2 | 72 |
| 399 | FISCHER | 1 | 2 | 72 |
| 400 | INCIDENCES | 2 | 2 | 72 |